Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001.

What Are Smart

Should WisdomTree U.S. MidCap Dividend ETF (DON) Be on Your Investing Radar?
Should WisdomTree U.S. MidCap Dividend ETF (DON) Be on Your Investing Radar?

The WisdomTree U.S. MidCap Dividend ETF (DON) was launched on June 16, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Mid Cap Value segment of the US

Should You Invest in the Invesco AI and Next Gen Software ETF (IGPT)?
Should You Invest in the Invesco AI and Next Gen Software ETF (IGPT)?

If you're interested in broad exposure to the Technology - Software segment of the equity market, look no further than the Invesco AI and Next Gen Software ETF (IGPT), a passively managed exchange

New Strong Buy Stocks for February 25th
New Strong Buy Stocks for February 25th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Swedbank AB (publ) SWDBY: This banking products and services provider has seen the Zacks Consensus Estimate for its current

New Strong Sell Stocks for February 25th
New Strong Sell Stocks for February 25th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Daiichi Sankyo Company, Limited DSNKY is a pharmaceutical company. The Zacks Consensus Estimate for its current year

3 Top-Ranked Healthcare Funds Positioned for Impressive Upside
3 Top-Ranked Healthcare Funds Positioned for Impressive Upside

Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions, and thus

Best Income Stocks to Buy for February 25th
Best Income Stocks to Buy for February 25th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, February 25:                     

Washington Trust Bancorp, Inc. WASH: This bank holding

Best Value Stocks to Buy for February 25th
Best Value Stocks to Buy for February 25th

Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 25:

Perdoceo Education Corporation PRDO: This postsecondary education provider carries

Bull of the Day: Albermarle (ALB)
Bull of the Day: Albermarle (ALB)

Albemarle Corporation: A premier Specialty Chemicals Company

Zacks Rank #1 (Strong Buy) stock Albermarle (ALB) is a leading specialty chemicals company, best-known as being the world’s largest

Bear of the Day: Upstart (UPST)
Bear of the Day: Upstart (UPST)

Upstart: An AI-driven Lending Platform

Zacks Rank #5 (Strong Sell) stock Upstart (UPST) manages an AI-powered lending platform. The San Mateo, California-based company partners with financial

Best Growth Stocks to Buy for February 25th
Best Growth Stocks to Buy for February 25th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 25:

Analog Devices, Inc. ADI: This semiconductor company carries a Zacks Rank #1, and

Zeta Global Holdings (ZETA) Q4 Earnings and Revenues Top Estimates
Zeta Global Holdings (ZETA) Q4 Earnings and Revenues Top Estimates

Zeta Global Holdings (ZETA) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.2 per share a year ago

Tigo Energy, Inc. (TYGO) Reports Q4 Loss, Misses Revenue Estimates
Tigo Energy, Inc. (TYGO) Reports Q4 Loss, Misses Revenue Estimates

Tigo Energy, Inc. (TYGO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.44 per share a year ago. These

UFP Technologies (UFPT) Q4 Earnings Top Estimates
UFP Technologies (UFPT) Q4 Earnings Top Estimates

UFP Technologies (UFPT) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.46 per share a year ago. These

Universal Insurance Holdings (UVE) Q4 Earnings and Revenues Surpass Estimates
Universal Insurance Holdings (UVE) Q4 Earnings and Revenues Surpass Estimates

Universal Insurance Holdings (UVE) came out with quarterly earnings of $2.17 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $0.25 per share a year

Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Alcon (ALC) reported $2.7 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 9.1%. EPS of $0.78 for the same period compares to $0.72 a year ago.

The

Sun Communities (SUI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sun Communities (SUI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Sun Communities (SUI) reported $515.2 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 30.9%. EPS of $1.40 for the same period compares to -$1.77 a

Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say
Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say

Supernus Pharmaceuticals (SUPN) reported $211.57 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 21.5%. EPS of $0.92 for the same period compares to

Here's What Key Metrics Tell Us About American Integrity Insurance (AII) Q4 Earnings
Here's What Key Metrics Tell Us About American Integrity Insurance (AII) Q4 Earnings

For the quarter ended December 2025, American Integrity Insurance (AII) reported revenue of $68.05 million, representing no change compared to the same period last year. EPS came in at $1.11

Compared to Estimates, MercadoLibre (MELI) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, MercadoLibre (MELI) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2025, MercadoLibre (MELI) reported revenue of $8.76 billion, up 44.6% over the same period last year. EPS came in at $11.03, compared to $12.61 in the year-ago

Flywire (FLYW) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Flywire (FLYW) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2025, Flywire (FLYW) reported revenue of $152.7 million, up 35.4% over the same period last year. EPS came in at $0, compared to -$0.12 in the year-ago quarter.

The

Compared to Estimates, Light & Wonder (LNWO) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Light & Wonder (LNWO) Q4 Earnings: A Look at Key Metrics

For the quarter ended December 2025, Light & Wonder (LNWO) reported revenue of $891 million, up 11.8% over the same period last year. EPS came in at $1.96, compared to $1.42 in the year-ago quarter.

Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics
Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics

Evolent Health (EVH) reported $468.72 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 27.5%. EPS of $0.08 for the same period compares to -$0.02 a

SPX Technologies (SPXC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
SPX Technologies (SPXC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2025, SPX Technologies (SPXC) reported revenue of $637.3 million, up 19.4% over the same period last year. EPS came in at $1.88, compared to $1.51 in the year-ago

Here's What Key Metrics Tell Us About Globus Medical (GMED) Q4 Earnings
Here's What Key Metrics Tell Us About Globus Medical (GMED) Q4 Earnings

For the quarter ended December 2025, Globus Medical (GMED) reported revenue of $826.42 million, up 25.7% over the same period last year. EPS came in at $1.28, compared to $0.84 in the year-ago